Ramazanoglu, M. Et Al. 2011. The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration. CLINICAL ORAL IMPLANTS RESEARCH , vol.22, no.12 , 1433-1439.

Ramazanoglu, M., LUTZ, R., Ergun, C., VON WILMOWSKY, C., NKENKE, E., & SCHLEGEL, K. A., (2011). The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration. CLINICAL ORAL IMPLANTS RESEARCH , vol.22, no.12, 1433-1439.

Ramazanoglu, Mustafa Et Al. "The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration," CLINICAL ORAL IMPLANTS RESEARCH , vol.22, no.12, 1433-1439, 2011

Ramazanoglu, Mustafa Et Al. "The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration." CLINICAL ORAL IMPLANTS RESEARCH , vol.22, no.12, pp.1433-1439, 2011

Ramazanoglu, M. Et Al. (2011) . "The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration." CLINICAL ORAL IMPLANTS RESEARCH , vol.22, no.12, pp.1433-1439.

@article{article, author={Mustafa Ramazanoglu Et Al. }, title={The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration}, journal={CLINICAL ORAL IMPLANTS RESEARCH}, year=2011, pages={1433-1439} }